Aspira Women's Health signs $4.7M common stock offering at $2.75/share to investors

Aspira Women's Health Inc.

Sells 1,650,473 shares at $2.75/share to investors and 44,347 shares at $3.98/share to directors/officers.
Gross proceeds ~$4.7M before fees; closing expected July 24, 2023.
Placement agent A.G.P./Alliance Global Partners receives 7% fee (3.5% on insider shares).
Officers and directors enter 90-day lock-up agreements restricting sale of company securities.
No pre-funded warrants were sold in the offering.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Aspira Women's Health Inc. entered into Securities Purchase Agreement with several investors (the Purchasers) valued at approximately $4.7 million (effective 2023-07-20).

Action: entry
Agreement: equity purchase
Counterparty: several investors (the Purchasers)
Value: approximately $4.7 million
Effective: 2023-07-20

Exact text from the filing

On July 20, 2023, Aspira Women’s Health Inc., or Aspira, entered into a securities purchase agreement, or the Purchase Agreement, with several investors, or the Purchasers, relating to the issuance and sale of an aggregate of 1,694,820 shares of its common stock, par value $0.001 per share, or the Offering.

View on SEC.gov

85 material agreements filed in the last 30 days. Browse all material agreements →

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-192338

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.